In this study, we performed RNA-Seq on purified bone marrow CD34+ cells from 12 MDS patients, eight with ring sideroblasts and SF3B1 mutation and four without mutation in other splicing factor genes, and from five healthy controls. The gene discussed is SF3B1; the disease is myelodysplastic syndrome.